Results Add to Growing Body of Evidence that Inhibiting PP2A with LB–100 May Be a…
TAMPA, Fla. and MENLO PARK, Calif., May 30, 2023 (GLOBE NEWSWIRE) — Morphogenesis, Inc. (“Morphogenesis”),…
TAMPA, Fla. and MENLO PARK, Calif., May 30, 2023 (GLOBE NEWSWIRE) — Morphogenesis, Inc. (“Morphogenesis”),…
CORAL GABLES, Fla., May 30, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq:…
CORAL GABLES, Fla., May 30, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq:…
CAMBRIDGE, Mass., May 30, 2023 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology…
CAMBRIDGE, Mass., May 30, 2023 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology…
BOSTON, May 30, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
BOSTON, May 30, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage…
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage…
New data show continued durability of response over 14 months with humoral immune responses increasing…
New data show continued durability of response over 14 months with humoral immune responses increasing…
BRISBANE, Calif., May 30, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage…
BRISBANE, Calif., May 30, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage…
CHICAGO and FORT WORTH, Texas, May 30, 2023 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (Actuate),…
CHICAGO and FORT WORTH, Texas, May 30, 2023 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (Actuate),…
WATERTOWN, Mass., May 30, 2023 (GLOBE NEWSWIRE) — Larkspur Biosciences, a biotechnology company building the…
WATERTOWN, Mass., May 30, 2023 (GLOBE NEWSWIRE) — Larkspur Biosciences, a biotechnology company building the…
Selected for Oral Presentation Study done in the CMT1A mouse model Supported by the CMT…